Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 6 (2009), Issue 7 (July)

1. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
   J Natl Cancer Inst, 101(13): 928-37. [Abstract] [Full-text]
2. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
   Hematol Oncol Clin North Am, 23(4): 873-902. [Abstract] [Full-text]
3. Hodgkin lymphoma.
   Hematol Oncol Clin North Am, 23(4): 747-68. [Abstract] [Full-text]
4. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.
   Leuk Res, 33(10): 1352-6. [Abstract] [Full-text]
5. Recombinant bispecific single chain antibody fragments induce Fc gamma-receptor-mediated elimination of CD30+ lymphoma cells.
   Cancer Lett, 282(2): 187-94. [Abstract] [Full-text]
6. Lymphatic drainage patterns in breast cancer patients who previously underwent mantle field radiation.
   Ann Surg Oncol, 16(8): 2295-9. [Abstract] [Full-text]
7. The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
   Ann Hematol, 88(9): 855-61. [Abstract] [Full-text]
8. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
   Diagn Cytopathol, 37(8): 564-73. [Abstract] [Full-text]
9. A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
   Clin Pharmacol Ther, 86(2): 190-6. [Abstract] [Full-text]
10. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
    Int J Cancer, 125(6): 1334-42. [Abstract] [Full-text]
11. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
    Int J Cancer, 125(5): 1092-101. [Abstract] [Full-text]
12. Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.
    PLoS One, 4(7): e6341. [Abstract] [Full-text]
13. Challenging complications of treatment--human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case report.
    Virol J, 6: 111. [Abstract] [Full-text]
14. Nodular lymphocyte predominant Hodgkin lymphoma.
    Oncologist, 14(7): 739-51. [Abstract] [Full-text]
15. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
    Mod Pathol, 22(8): 1006-15. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.